1. Home
  2. BVS vs KREF Comparison

BVS vs KREF Comparison

Compare BVS & KREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • KREF
  • Stock Information
  • Founded
  • BVS 2011
  • KREF 2014
  • Country
  • BVS United States
  • KREF United States
  • Employees
  • BVS N/A
  • KREF N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • KREF Real Estate Investment Trusts
  • Sector
  • BVS Health Care
  • KREF Real Estate
  • Exchange
  • BVS Nasdaq
  • KREF Nasdaq
  • Market Cap
  • BVS 883.7M
  • KREF 833.5M
  • IPO Year
  • BVS 2021
  • KREF 2017
  • Fundamental
  • Price
  • BVS $11.24
  • KREF $11.26
  • Analyst Decision
  • BVS Strong Buy
  • KREF Buy
  • Analyst Count
  • BVS 2
  • KREF 6
  • Target Price
  • BVS $16.00
  • KREF $12.83
  • AVG Volume (30 Days)
  • BVS 489.1K
  • KREF 538.0K
  • Earning Date
  • BVS 11-05-2024
  • KREF 10-21-2024
  • Dividend Yield
  • BVS N/A
  • KREF 8.88%
  • EPS Growth
  • BVS N/A
  • KREF N/A
  • EPS
  • BVS N/A
  • KREF N/A
  • Revenue
  • BVS $555,061,000.00
  • KREF $66,587,000.00
  • Revenue This Year
  • BVS $11.24
  • KREF N/A
  • Revenue Next Year
  • BVS $6.77
  • KREF N/A
  • P/E Ratio
  • BVS N/A
  • KREF N/A
  • Revenue Growth
  • BVS 10.40
  • KREF 9.58
  • 52 Week Low
  • BVS $3.67
  • KREF $8.71
  • 52 Week High
  • BVS $14.38
  • KREF $14.12
  • Technical
  • Relative Strength Index (RSI)
  • BVS 41.28
  • KREF 34.80
  • Support Level
  • BVS $7.30
  • KREF $11.83
  • Resistance Level
  • BVS $12.61
  • KREF $12.21
  • Average True Range (ATR)
  • BVS 0.97
  • KREF 0.31
  • MACD
  • BVS -0.25
  • KREF -0.04
  • Stochastic Oscillator
  • BVS 55.65
  • KREF 3.60

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About KREF KKR Real Estate Finance Trust Inc.

KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.

Share on Social Networks: